Amgen, Novartis start Phase II to prevent AD

In August, Novartis AG (NYSE:NVS; SIX:NOVN), Amgen Inc. (NASDAQ:AMGN) and the Banner Alzheimer’s Institute (BAI) began the Phase II Alzheimer’s Prevention Initiative (API) Generation Study 2 to evaluate

Read the full 285 word article

User Sign In